Why Novavax's Stock Is Trading Higher Today

Comments
Loading...

Novavax Inc NVAX is trading significantly higher Monday amid renewed COVID-19 concerns. 

The recent spread of the COVID-19 Delta variant is a major concern. Delta first appeared in India at the end of 2020. The highly contagious COVID-19 variant surfaced in the United States in March and is now the dominant strain.

Novavax is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases.

Novavax's COVID-19 vaccine, NVX-CoV2373, is currently in two pivotal Phase 3 studies to evaluate vaccine efficacy, safety and immunogenicity.

Price Action: Novavax has traded as high as $331.68 and as low as $76.59 over a 52-week period.

At last check Monday, the stock was up 12.50% at $210.

NVAX Logo
NVAXNovavax Inc
$8.14-2.40%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum76.40
Growth86.03
Quality-
Value26.86
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Posted In: